Drug Development, Health Technology, Survey and Tools

Deliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development

Digital Health Global

JANUARY 26, 2024

NEW YORK–(BUSINESS WIRE)– Deliberate AI , a digital health technology company that delivers precision measurement of mental health through AI, today announced its inclusion in the U.S. Food and Drug Administration (FDA) Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program.

Drug Development

Drug Development Mental health Psychiatry Digital Health

Digital Health Technologies in Clinical Trials

Digital Health Global

NOVEMBER 30, 2023

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings.

Health Technology

Health Technology Digital Health Life Science BioTech

The outlook for healthcare in 2022

Waracle

JANUARY 5, 2022

Whether it is in operational delivery, service provision, patient enablement or drug discovery, technology has continued to create wide scale impact as we shift towards a post-pandemic world. But that is something that AR and VR technology have the potential to enhance in the future.

Patient Experience

Patient Experience Drug Development Digital Health Remote care

Connected Health Pulse

Deliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development

Digital Health Technologies in Clinical Trials

The outlook for healthcare in 2022

Stay Connected